Chronic Pain Diagnosis and Treatment in Torture Survivors
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Nov 11, 2020
Trial Information
Current as of September 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and improving how we diagnose and treat chronic pain in individuals who have survived torture. The researchers believe that by using a special pain questionnaire alongside existing guidelines from the United Nations, they can detect pain more effectively in these survivors—raising the detection rate from 15% to as high as 90%. They will also conduct interviews to learn how acceptable pain treatments are to these individuals and explore how easy it is to enroll and keep people in a digital pain management program over six months.
To be eligible for the trial, participants must be at least 18 years old, have survived torture as defined by the World Medical Association, and be willing to be contacted by the research team. Those with chronic pain will be included in the later stages of the study. Participants should have a personal smartphone for the digital program, and it’s important to note that non-tortured refugees seeking asylum or pregnant women are not eligible. If you join this trial, you can expect to share your experiences and help improve the understanding and treatment of chronic pain for torture survivors.
Gender
ALL
Eligibility criteria
- • (Aim 1)
- Inclusion Criteria:
- • ≥ 18 years old
- • Survived torture as defined by the World Medical Association
- • Consented to being contacted by our research team
- Exclusion Criteria:
- • Non-tortured refugees seeking asylum through T visas (trafficking), U visas (victims of violence in the US), Violence Against Women Act (VAMA), and Special Immigrant Juveniles (SIJ)
- • Pregnant women
- • (Aim 2)
- Inclusion Criteria:
- • ≥ 18 years old
- • Survived torture as defined by the World Medical Association
- • Chronic pain as per Aim 1 findings
- Exclusion Criteria:
- • Non-tortured refugees seeking asylum through T visas (trafficking), U visas (victims of violence in the US), Violence Against Women Act (VAMA), and Special Immigrant Juveniles (SIJ)
- • Pregnant women
- • (Aim 3): Inclusion Criteria
- • ≥ 18 years old
- • Survived torture as defined by the World Medical Association
- • Chronic pain as per Aim 1 findings
- • Personal smartphone
- • Exclusion Criteria
- • Non-tortured refugees seeking asylum through T visas (trafficking), U visas (victims of violence in the US), Violence Against Women Act (VAMA), and Special Immigrant Juveniles (SIJ)
- • Pregnant women
- • Planned move within 6 months
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
New York, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Gunisha Kaur, MA, MD
Principal Investigator
Weill Medical College of Cornell University
Claudia Hatef, BS
Study Director
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials